Gene · 155
Papers3,802
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 3,802
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Intermittent Hypoxia and Atherosclerosis: From Molecular Mechanisms to the Therapeutic Treatment. | Oxid Med Cell Longev | 2022 | 35965683 | PubTator, text mining | PubMed |
| Gi-protein-coupled β 1-adrenergic receptor: re-understanding the selectivity of β 1-adrenergic receptor to G protein. | Acta Biochim Biophys Sin (Shanghai) | 2022 | 35959878 | PubTator, text mining | PubMed |
| Early-Onset Diabetes Mellitus in Chromosome 8p11.2 Deletion Syndrome Combined With Becker Muscular Dystrophy - A Case Report. | Front Endocrinol (Lausanne) | 2022 | 35957837 | PubTator, text mining | PubMed |
| Immunological Tolerance in Liver Transplant Recipients: Putative Involvement of Neuroendocrine-Immune Interactions. | Cells | 2022 | 35954171 | PubTator, text mining | PubMed |
| Gestational Nutrition as a Predisposing Factor to Obesity Onset in Offspring: Role for Involvement of Epigenetic Mechanism. | Niger J Physiol Sci | 2022 | 35947841 | PubTator, text mining | PubMed |
| Development of a genetic risk score for obesity predisposition evaluation. | Mol Genet Genomics | 2022 | 35947209 | PubTator, text mining | PubMed |
| Synthesis of a boron-containing amidoxime reagent and its application to synthesize functionalized oxadiazole and quinazolinone derivatives. | Tetrahedron Lett | 2022 | 35935920 | PubTator, text mining | PubMed |
| Mirabegron relaxes arteries from human visceral adipose tissue through antagonism of α1-adrenergic receptors. | Vascul Pharmacol | 2022 | 35934296 | PubTator, text mining | PubMed |
| Immune cell cholinergic signaling in adipose thermoregulation and immunometabolism. | Trends Immunol | 2022 | 35931611 | PubTator, text mining | PubMed |
| Zeaxanthin remodels cytoplasmic lipid droplets via β3-adrenergic receptor signaling and enhances perilipin 5-mediated lipid droplet-mitochondrion interactions in adipocytes. | Food Funct | 2022 | 35924967 | PubTator, text mining | PubMed |
| Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics. | Signal Transduct Target Ther | 2022 | 35918332 | PubTator, text mining | PubMed |
| Strategies to improve homology-based repair outcomes following CRISPR-based gene editing in mosquitoes: lessons in how to keep any repair disruptions local. | Virol J | 2022 | 35908059 | PubTator, text mining | PubMed |
| Association Between Trp64Arg Polymorphism of Beta-3 Adrenergic Receptor Gene and Susceptibility to Overactive Bladder: A Meta-Analysis. | Front Genet | 2022 | 35903356 | PubTator, text mining | PubMed |
Weight loss-induced improvement of body weight and insulin sensitivity is not amplified by a subsequent 12-month weight maintenance intervention but is predicted by adaption of adipose atrial natriuretic peptide system: 48-month results of a randomized controlled trial. | BMC Med | 2022 | 35897098 | PubTator, text mining | PubMed |
| Sex/Gender- and Age-Related Differences in β-Adrenergic Receptor Signaling in Cardiovascular Diseases. | J Clin Med | 2022 | 35893368 | PubTator, text mining | PubMed |
| Targeting skeletal muscle mitochondrial health in obesity. | Clin Sci (Lond) | 2022 | 35892309 | PubTator, text mining | PubMed |
| Obesity and Endothelial Function. | Biomedicines | 2022 | 35885049 | PubTator, text mining | PubMed |
| Subcellular β-Adrenergic Receptor Signaling in Cardiac Physiology and Disease. | J Cardiovasc Pharmacol | 2022 | 35881897 | PubTator, text mining | PubMed |
| Xanthine oxidase inhibitor urate-lowering therapy titration to target decreases serum free fatty acids in gout and suppresses lipolysis by adipocytes. | Arthritis Res Ther | 2022 | 35879786 | PubTator, text mining | PubMed |
| The Role of Thermogenic Fat Tissue in Energy Consumption. | Curr Issues Mol Biol | 2022 | 35877443 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/155/papers?page=30